Showing results (141-150 of 161) with videos related to
Sort By:
Pageof 17
BJU International|April 14, 2025
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatmentIvo I de Vos, Cristina Marenghi, Fabio Badenchini, et al.Plos One|January 24, 2014
Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responsesRafael Fenutría, Vanesa G Martinez, Inês Simões, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 13, 2025
Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trialJose M Miro, Ferran Torres, Christian Manzardo, et al.The Journal of Rheumatology|November 3, 2014
Etiopathogenic role of surfactant protein d in the clinical and immunological expression of primary Sjögren syndromeMaría José Soto-Cárdenas, Myriam Gandía, Pilar Brito-Zerón, et al.Frontiers in Immunology|April 18, 2024
C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degenerationLena Giralt, Marc Figueras-Roca, Beatriz De Luis Eguileor, et al.The Journal of Experimental Medicine|July 6, 2016
CD6 modulates thymocyte selection and peripheral T cell homeostasisMarc Orta-Mascaró, Marta Consuegra-Fernández, Esther Carreras, et al.Hepatology (Baltimore, Md.)|November 21, 2020
Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against InfectionsElisa Pose, Mar Coll, Celia Martínez-Sánchez, et al.Cellular & Molecular Immunology|December 12, 2017
Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasisMarta Consuegra-Fernández, Marc Julià, Mario Martínez-Florensa, et al.International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical TrialOscar Arrieta, Norma Hernández-Pedro, Federico Maldonado, et al.Lung Cancer (Amsterdam, Netherlands)|January 1, 2021
Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 studyMónika Blake-Cerda, Francisco Lozano-Ruíz, Federico Maldonado-Magos, et al.Pageof 17